Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2021Journal for ImmunoTherapy of CancerOpen Access

CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

BSBrett SchroederNational Cancer InstituteNLNatalie A. LaFranzoCofactor Genomics (United States)BLBonnie LaFleurUniversity of Arizona

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schroeder et al. (2021) studied this question.

synapsesocial.com/papers/69da066c0d540cafc58381behttps://doi.org/10.1136/jitc-2021-002812
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Regularization and Variable Selection Via the Elastic Net2005 · 21,773 citations
  2. 2Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced <i>CDK4</i> -Amplified Well-Differentiated or Dedifferentiated Liposarcoma2013 · 400 citations
  3. 3Overlap and Effective Size of the Human CD8 <sup>+</sup> T Cell Receptor Repertoire2010 · 424 citations
  4. 4T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas2017 · 277 citations
  5. 5Gene Expression Profiling of Liposarcoma Identifies Distinct Biological Types/Subtypes and Potential Therapeutic Targets in Well-Differentiated and Dedifferentiated Liposarcoma2007 · 244 citations